Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

Novo Nordisk logo

Novo Nordisk

Status

Completed

Conditions

Diabetes
Diabetes Mellitus, Type 2

Treatments

Drug: insulin detemir
Drug: insulin NPH

Study type

Observational

Funder types

Industry

Identifiers

NCT00715351
NN304-1896

Details and patient eligibility

About

This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control, weight change and hypoglycaemic effects in patients with type 2 diabetes with Levemir® compared to Insulatard® under normal clinical practice conditions.

Enrollment

342 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Type 2 diabetes failing on oral blood glucose lowering therapy, and requiring insulin therapy.

Exclusion criteria

  • Type 1 diabetes
  • Previous use of insulin

Trial design

342 participants in 2 patient groups

A
Treatment:
Drug: insulin detemir
B
Treatment:
Drug: insulin NPH

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems